Back to Search Start Over

Schimke immunoosseous dysplasia: defining skeletal features

Authors :
Lawrence R. Shoemaker
Jürgen Spranger
Robyn Cairns
Cristina Rusu
Jean Luc André
Barbara Hinkelmann
Beate Schmidt
Bertram F. Pontz
Doris Taha
Helen Fryssira
Guiliana Lama
Thomas Lücke
Jorge M. Saraiva
Stefan Fründ
David Goodman
Knut Helmke
Natasa Stajic
Petra Lamfers
Chantal Loirat
Sabine Sigaudy
Harika Alpay
Radovan Bogdanovic
Yumi Asakura
Silvia Majore
Kshamta B. Hunter
Dominique Bonneau
Sarah F. Smithson
Christy Mayfield
Cornelius F. Boerkoel
Karlien Cransberg
Mitochondrie : Régulations et Pathologie
Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Pediatrics
Hunter, Kshamta B.
Luecke, Thomas
Spranger, Juergen
Smithson, Sarah F.
Alpay, Harika
Andre, Jean-Luc
Asakura, Yumi
Bogdanovic, Radovan
Bonneau, Dominique
Cairns, Robyn
Cransberg, Karlien
Fruend, Stefan
Fryssira, Helen
Goodman, David
Helmke, Knut
Hinkelmann, Barbara
Lama, Guiliana
Lamfers, Petra
Loirat, Chantal
Majore, Silvia
Mayfield, Christy
Pontz, Bertram F.
Rusu, Cristina
Saraiva, Jorge M.
Schmidt, Beate
Shoemaker, Lawrence
Sigaudy, Sabine
Stajic, Natasa
Taha, Doris
Boerkoel, Cornelius F.
Source :
European Journal of Pediatrics, European Journal of Pediatrics, 2010, 169 (7), pp.801-811. ⟨10.1007/s00431-009-1115-9⟩, European Journal of Pediatrics, 169, 801-811. Springer-Verlag
Publication Year :
2009
Publisher :
Springer Science and Business Media LLC, 2009.

Abstract

Schimke immunoosseous dysplasia (SIOD) is an autosomal recessive multisystem disorder characterized by prominent spondyloepiphyseal dysplasia, T cell deficiency, and focal segmental glomerulosclerosis. Biallelic mutations in swi/snf-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1 (SMARCAL1) are the only identified cause of SIOD, but approximately half of patients referred for molecular studies do not have detectable mutations in SMARCAL1. We hypothesized that skeletal features distinguish between those with or without SMARCAL1 mutations. Therefore, we analyzed the skeletal radiographs of 22 patients with and 11 without detectable SMARCAL1 mutations. We found that patients with SMARCAL1 mutations have a spondyloepiphyseal dysplasia (SED) essentially limited to the spine, pelvis, capital femoral epiphyses, and possibly the sella turcica, whereas the hands and other long bones are basically normal. Additionally, we found that several of the adolescent and young adult patients developed osteoporosis and coxarthrosis. Of the 11 patients without detectable SMARCAL1 mutations, seven had a SED indistinguishable from patients with SMARCAL1 mutations. We conclude therefore that SED is a feature of patients with SMARCAL1 mutations and that skeletal features do not distinguish who of those with SED have SMARCAL1 mutations. Electronic supplementary material The online version of this article (doi:10.1007/s00431-009-1115-9) contains supplementary material, which is available to authorized users.

Details

ISSN :
14321076 and 03406199
Volume :
169
Database :
OpenAIRE
Journal :
European Journal of Pediatrics
Accession number :
edsair.doi.dedup.....75061c6bbd7529a743f53f8089870c9d